Comparison

PI 3 Kinase p85 alpha [U13]

Item no. 20-272-192017
Manufacturer GENWAY
Amount 1 ml
Category
Type Antibody
Applications WB, IP
Clone U13
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-BEAC62
Similar products 20-272-192017
Available
Genway ID:
GWB-BEAC62
Clone:
U13
Isotype:
IgG1
Immunogen:
Baculovirus expressed (recombinant) Bovine p85 alpha subunit of PI 3 Kinase.
Antigen Species:
Bovine
Specificity:
Recognizes the SH3 domain of the p85 alpha subunit of bovine PI 3 kinase.
Target:
PI 3 Kinase p85 alpha
Concentration:
Tissue Culture Supernatant Storage
Buffer:
0. 2M Tris/HCl pH7. 4 and 5-10% foetal calf serum containing 0. 09% sodium azide
Application Note:
For IP: Use at a neat dilution. For WB: Use at a dilution of 1:200. Not tested in other applications. Optimal dilutions/concentrations should be determined by the researcher. Myeloma: NS1 The enzyme PI-3-K phosphorylates at the D-3 position of the inositol ring of PI PI-4- phosphate and PI-4 5-biphosphate (PI-4 5-P2) to produce their respective PI3-phosphorylated derivatives. PI-3-K exists as a heterodimer of 85 kDa (p85) and 110 kDa (p110) subunits. The p85 subunit contains two SH2 domains and an SH3 domain. It has been shown to associate with and serve as a substrate for activated growth factor receptor tyrosine kinases. p85 may serve as regulator of the catalytic subunit p110 by acting as the link between PI-3-K and the ligand-activated receptor. Two distinct forms of the p85 subunit are described: p85 alpha which binds tightly to the catalytic subunit and p85 beta a protein of unknown function. Both isoforms bind to activated receptors and serve as tyrosine kinase substrates.
Function:
Binds to activated (phosphorylated) protein-Tyr kinases through its SH2 domain and acts as an adapter mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues.
Subunit:
Heterodimer of a p110 (catalytic) and a p85 (regulatory) subunits. Interacts with phosphorylated TOM1L1. Interacts with phosphorylated LIME1 upon TCR and/or BCR activation. Interacts with SOCS7. Interacts with RUFY3 (By similarity). Interacts with phosphorylated LAT LAX1 and TRAT1 upon TCR activation. Interacts with CBLB. Interacts with HIV-1 Nef to activate the Nef associated p21-activated kinase (PAK). This interaction depends on the C-terminus of both proteins and leads to increased production of HIV. Interacts with HCV NS5A. The SH2 domains interact with the YTHM motif of phosphorylated INSR in vitro. Also interacts with tyrosine-phosphorylated IGF1R in vitro. Interacts with CD28 and CD3Z upon T-cell activation. Interacts with IRS1 and phosphorylated IRS4 as well as with NISCH and HCST.
Tissue Specificity:
Isoform 2 is expressed in skeletal muscle and brain and at lower levels in kidney and cardiac muscle. Isoform 2 and isoform 4 are present in skeletal muscle (at protein level).
Domain:
The SH3 domain mediates the binding to CBLB and to HIV-1 Nef.
Ptm:
Polyubiquitinated in T-cells by CBLB; which does not promote proteasomal degradation but impairs association with CD28 and CD3Z upon T-cell activation.
Disease:
Defects in PIK3R1 are a cause of severe insulin resistance.
Similarity:
Belongs to the PI3K p85 subunit family.
Similarity:
Contains 1 Rho-GAP domain.
Similarity:
Contains 2 SH2 domains.
Similarity:
Contains 1 SH3 domain.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ml
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close